Conventional myelosuppressive chemotherapy for non-haematological malignancy disrupts the intestinal microbiome

Conventional myelosuppressive chemotherapy for non-haematological malignancy disrupts the intestinal microbiome

Abstract Background The gut microbiota influences many aspects of host physiology, including immune regulation, and is predictive of outcomes in cancer patients. However, whether conventional myelosuppressive chemotherapy affects the gut microbiota in humans with non-haematological malignancy, indep...

Full description

Bibliographic Details
Main Authors: Lito E. Papanicolas, Sarah K. Sims, Steven L. Taylor, Sophie J. Miller, Christos S. Karapetis, Steve L. Wesselingh, David L. Gordon, Geraint B. Rogers
Format: Article
Language:English
Published: BMC 2021-05-01
Series:BMC Cancer
Subjects:
Chemotherapy
Cancer
Microbiome
Online Access:https://doi.org/10.1186/s12885-021-08296-4

Internet

https://doi.org/10.1186/s12885-021-08296-4

Similar Items